Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

325.82
+6.111.91%
Post-market: 325.820.00000.00%18:31 EDT
Volume:317.05K
Turnover:103.04M
Market Cap:14.70B
PE:12.98
High:326.30
Open:322.99
Low:322.60
Close:319.71
Loading ...

United Therapeutics Corp (UTHR) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com
·
27 Feb

Q4 2024 United Therapeutics Corp Earnings Call

Thomson Reuters StreetEvents
·
27 Feb

Positive Outlook for United Therapeutics: Buy Rating Supported by Strong Performance and Growth Prospects

TIPRANKS
·
27 Feb

Why United Therapeutics (UTHR) Stock Is Down Today

StockStory
·
27 Feb

United Therapeutics Slides Toward Steepest Decrease in Three Years After 4Q Earnings Miss

Dow Jones
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences

Reuters
·
27 Feb

United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat

Zacks
·
26 Feb

Stock Track | United Therapeutics Plummets 6.85% in Pre-Market as Q4 Earnings Miss Estimates

Stock Track
·
26 Feb

United Therapeutics Shares Down 4.9% After Q4 Profit Miss

THOMSON REUTERS
·
26 Feb

United Therapeutics Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

BUZZ-United Therapeutics falls on quarterly profit miss

Reuters
·
26 Feb

Sector Update: Health Care Stocks Decline Pre-Bell Wednesday

MT Newswires Live
·
26 Feb

United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates

Zacks
·
26 Feb

United Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

United Therapeutics Q4 Net Income Increases, Revenue Drops

MT Newswires Live
·
26 Feb

United Therapeutics Q4 2024 GAAP EPS $6.19 Misses $6.27 Estimate, Sales $735.90M Beat $734.74M Estimate

Benzinga
·
26 Feb

BRIEF-United Therapeutics Q4 Revenue USD 735.9 Million Vs. IBES Estimate USD 734.7 Million

Reuters
·
26 Feb

United Therapeutics Q4 Net Income USD 301.3 Million

THOMSON REUTERS
·
26 Feb

United Therapeutics Corp - Q4 EPS $6.19

THOMSON REUTERS
·
26 Feb

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
26 Feb